Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1996-09-13
2000-06-27
Goldberg, Jerome D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
A61K 3144
Patent
active
060807512
ABSTRACT:
A method of treating human pancreatic cancer with water-insoluble 20(S)-camptothecin compounds with the closed-lactone ring intact and/or derivatives thereof is disclosed. The method includes preferably administering the compounds intramuscularly, orally, and transdermally.
REFERENCES:
patent: Re32518 (1987-10-01), Miyasaka et al.
patent: 3894029 (1975-07-01), Winterfeldt et al.
patent: 4031098 (1977-06-01), Sugasawa
patent: 4357422 (1982-11-01), Giard et al.
patent: 4399276 (1983-08-01), Miyasaka et al.
patent: 4399282 (1983-08-01), Miyasaka et al.
patent: 4473692 (1984-09-01), Miyasaka et al.
patent: 4513138 (1985-04-01), Miyasaka et al.
patent: 4545880 (1985-10-01), Miyasaka et al.
patent: 4604463 (1986-08-01), Miyasaka et al.
patent: 4774236 (1988-09-01), Cook et al.
patent: 4867978 (1989-09-01), Gold
patent: 4874779 (1989-10-01), Senter
patent: 4894456 (1990-01-01), Wall et al.
patent: 4904768 (1990-02-01), Saulnier et al.
patent: 4914205 (1990-04-01), Sawada et al.
patent: 4939255 (1990-07-01), Tagawa et al.
patent: 4943579 (1990-07-01), Vishnuvajjala et al.
patent: 4981968 (1991-01-01), Wall et al.
patent: 5004758 (1991-04-01), Boehm et al.
patent: 5041424 (1991-08-01), Saulnier et al.
patent: 5049668 (1991-09-01), Wall et al.
patent: 5053512 (1991-10-01), Wani et al.
patent: 5061795 (1991-10-01), Tagawa et al.
patent: 5061800 (1991-10-01), Yaegashi et al.
patent: 5064823 (1991-11-01), Lee et al.
patent: 5106742 (1992-04-01), Wall et al.
patent: 5122526 (1992-06-01), Wall et al.
patent: 5122606 (1992-06-01), Wani et al.
patent: 5126351 (1992-06-01), Luzzio et al.
patent: 5145684 (1992-09-01), Liversidge et al.
patent: 5155225 (1992-10-01), Fortunak et al.
patent: 5162532 (1992-11-01), Comins et al.
patent: 5180722 (1993-01-01), Wall et al.
patent: 5225404 (1993-07-01), Giovanella et al.
1992 AACR Abstract Form, "Pharmacokinetics of Tritum Labeled Camptothecin in Nude Mice," Smith, P.L. et al.
1992 AACR Abstract Form, "Growth Inhibition of Human cancer Metasteses in the Xenograft Model by Camptothecin [NSC 94600], 9-amino (NSC 60371] and 9-nitrocamptothecin," Potmesil, M.
Giovanella et al., Cancer Research, vol. 51, pp. 3052-3055, Jun. 1, 1991.
Kharbanda et al., Cancer Research, vol. 51, pp. 6636-6642, Dec. 15, 1991.
The Alkaloids, vol. XXV, Chapter 1, "Antitumor Alklaoids," Suffness et al., pp. 73-89, copyright 1985, Academic Press, Inc.
Wall et al., "New Type of 9-Nitrocamptothecin and a Method of its Production," J. Am. Chem. Soc., vol. 88, No. 16, pp. 3888-3890, Aug. 20, 1966.
Hsiang, Y.-H. et al., Cancer Res. 48: 1722-1726, 1988.
Wani, M.C. et al., J. Med. Chem. 30: 1774-1779, 1987.
Wani, M.C. et al., J. Med. Chem 29: 2358-2363, 1986.
Hsiang, Y.-H. et al., J. Biol. Chem 97: 14873-14878, 1985.
Hsiang, Y.-H. et al., Abstract 683 from The American Association for Cancer Research, vol. 29, Mar. 1988.
Wall, M.E. et al., J. Med. Chem. 29: 1553-1555, 1986.
Nelson, W.G. et al., Cancer Res. 47: 3246-3250, 1987.
Hsiang, Y.-H. et al., Cancer Res. 49: 4386-4389, 1989.
Wani, M.C. et al., J. Med. Chem. 30: 2317-2319, 1987.
Giovanella, B.C. et al., Cancer 52: 1146-1152, 1983.
Wani, M.C. et al., J. Med. Chem. 23: 554-560, 1980.
Leibovitz, A. et al., Cancer Res. 36: 4562-4569, 1976.
Fogh, J. et al., in "Human Tumor Cells In Vitro," Fogh, Jr. et., Plenum Press, New York, 1976, pp. 115-141.
Liu, L.F. et al., Proc. Nat'l. Acad. Sci. USA, 78: 3487-3491, 1981.
Muggla, F.M. et al., Cancer Chemo. Rep. 56: 515-521, 1972.
Gottlieb, J.A. et al., Cancer Chemo. Rep. 54: 461-470, 1970.
Jaxel,C. et al., Cancer Res. 49: 1465-1469, 1989.
Potmesil, M. et al., Cancer Res. 48: 3537-3543, 1988.
Chemical Abstracts, vol. 106(25), Abstract No. 207285z (1987).
Chemical Abstracts, vol. 106(15), Abstract No. 120133z (1987).
Chemical Abstracts,vol. 106(15), Abstract No. 11479a (1987).
Chemical Abstracts,vol. 106(13), Abstract No. 95753s (1987).
Chemical Abstracts, vol. 103(9), Abstract No. 64374c (1985).
Chemical Abstracts, vol. 101, Abstract No. 130677r (1984).
Chemical Abstracts, vol. 101(11), Abstract No. 91322z (1982).
Chemical Abstracts, vol. 101(10), Abstract No. 78770z (1984).
Chemical Abstracts, vol. 100(21), Abstract No. 167724j (1983).
Chemical Abstracts, vol. 100, Abstract No. 139434w (1984).
Chemical Abstracts, vol. 97, Abstract No. 188278b (1982).
Chemical Abstracts, vol. 96(9), Abstract No. 69271p (1981).
Chemical Abstracts, vol. 95(15), Abstract No. 133209h (1981).
Chemical Abstracts, vol. 94(1), Abstract No. 4143n (1980).
Chemical Abstracts, vol. 92(5), Abstract No. 37766e (1980).
Chemical Abstracts, vol. 92(3), Abtract No. 18799b (1980).
Chemical Abstracts, vol. 90(4), Abstract No. 28930k (1979).
Chemical Abstracts, vol. 90(3), Abstract No. 22857v (1979).
Chemical Abstracts, vol. 84, Abstract No. 115629p (1976).
Chemical Abstracts, vol. 94(12), Abstract No. 90169e (1980).
Derwent 89-179979/25.
Nicholas et al., J. Med. Chem., vol. 33, No. 3, pp. 972-978, 1990.
Ohro et al., Proc. Ann. Meet Am. Soc. Clin. Oncol., 8: A1019, 1989.
Hertzberg et al., J. Med. Chem., vol. 32(3), pp. 715-720, 1989.
Hsiang et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 30: A2476, 1989.
Hertzberg et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 30: A2485, 1989.
Pommier et al., Proc. Ann. Meet. Am. Assoc. Cancer Res., 29: A1080, 1988.
Lin et al., Yao Hsueh Hsueh Pao, vol. 23(3), pp. 186-188 (1988).
Ronman et al., Journal of Labelled Compounds and Radiopharmaceuticals, vol. 18(3), pp. 319-329, 1981.
Danishefky et al., J. Org. Chem., vol. 39(28), pp. 3430-3432, 1974.
Plattner et al., J. Org. Chem., vol. 39(3), pp. 303-311, 1974.
Plattner et al., J. Amer. Chem. Soc., vol. 94(24), pp. 8615-8616, 1972.
Govindachari et al., "9-Methoxycamptothecin: a New Alkaloid from Mappie voetida Miers,"pp. 453-454.
Giovanella et al., Science, vol. 246, pp. 1046-1048, 1989.
Xi-Ran et al., "Topical Camptothecine in Treatment of Psoriasis," Int'l Journal of Dermatology, vol. 27, No. 7, pp. 475-476, Sep. 1988.
Ching-jung et al., "Effect of Topical Use of Camptothecine-Dimethyl Sulfoxide Solution in Psoriasis," Chinese Medical Journal, vol. 1, No. 5, pp. 355-360, Sep. 1975.
Tung et al., "Camptothecin Instillation and Local Injection for Prevention and Treatment of Urinary Bladder Tumors," Chinese Medical Journal, vol. 92, No. 1, pp. 57-60, 1979.
Pantazis et al., "Complete Inhibition of Growth Followed by Death of Human Malignant Melanoma Cells in Vitro and Regression of Human Melanoma Xenografts in Immunodeficient Mice Induced by Camptothecin," Cancer Research, vol. 52, No. 14, pp. 3980-3987, Jul. 15, 1992.
Cancer Research 5. 3980-3987, Jul. 15, 1992; "Complete Inhibition of Growth followed by Death of Human Malignant Melanoma Cells in Vitro and Regression of Human Melanoma Xenografts in Immunodeficient Mice Induced by Camptothecins.sup.1."
Giovanella Beppino C.
Kozielski Anthony J.
Natelson Ethan A.
Stehlin John S.
Goldberg Jerome D.
The Stehlin Foundation for Cancer Research
LandOfFree
Method for treating pancreatic cancer in humans with water-insol does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for treating pancreatic cancer in humans with water-insol, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for treating pancreatic cancer in humans with water-insol will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1784949